Company Overview of Nautilus Neurosciences, Inc.
Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, engages in identifying and developing drugs for neurological disorders. It offers CAMBIATM, a prescription medicine for migraine attacks in adults. The company was incorporated in 2009 and is based in Bedminster, New Jersey.
135 Route 202/206
Bedminster, NJ 07921
Founded in 2009
Key Executives for Nautilus Neurosciences, Inc.
Nautilus Neurosciences, Inc. Key Developments
Similar Private Companies By Industry
|IDEXX Pharmaceuticals, Inc.||United States|
|The McConnell Group, Inc.||United States|
|Akorn Ophthalmics, Inc.||United States|
|Divergence, Inc.||United States|
|Cryometrix Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- Detroit, MI | AstraZenecaPosted: Dec 09
- San Francisco, CA | JobvertisePosted: Nov 30
- Princeton, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact Nautilus Neurosciences, Inc., please visit www.nautilusneurosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.